Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer March 29, 2017 <b>Trump</b> Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals March 15, 2017 Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017
<b>Trump</b> Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals March 15, 2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's July 11, 2017
